Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2019 3
2020 5
2021 5
2022 4
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all The following term was ignored: ) Quoted phrases not found in phrase index: "Medication assisted maintenance treatment", "Buprenorphine assisted maintenance treatment"
Page 1
Cannabis and Psychosis Through the Lens of DSM-5.
Pearson NT, Berry JH. Pearson NT, et al. Among authors: berry jh. Int J Environ Res Public Health. 2019 Oct 28;16(21):4149. doi: 10.3390/ijerph16214149. Int J Environ Res Public Health. 2019. PMID: 31661851 Free PMC article. Review.
Long-term treatment retention in West Virginia's comprehensive opioid addiction treatment (COAT) program.
Lander LR, Zheng W, Hustead JD, Mahoney JJ 3rd, Berry JH, Marshalek P, Winstanley EL. Lander LR, et al. Among authors: berry jh. J Neurol Sci. 2020 Apr 15;411:116712. doi: 10.1016/j.jns.2020.116712. Epub 2020 Feb 3. J Neurol Sci. 2020. PMID: 32058182 Free PMC article. Review.
BACKGROUND: The United States continues to experience an opioid epidemic of unprecedented proportions despite FDA approval of life saving medications, such as buprenorphine. ...This model, known as the Comprehensive Opioid Addiction Treatment (C …
BACKGROUND: The United States continues to experience an opioid epidemic of unprecedented proportions despite FDA approval of life sa …
Deep brain stimulation for psychiatric disorders and behavioral/cognitive-related indications: Review of the literature and implications for treatment.
Mahoney JJ 3rd, Koch-Gallup N, Scarisbrick DM, Berry JH, Rezai AR. Mahoney JJ 3rd, et al. Among authors: berry jh. J Neurol Sci. 2022 Jun 15;437:120253. doi: 10.1016/j.jns.2022.120253. Epub 2022 Apr 10. J Neurol Sci. 2022. PMID: 35460949 Review.
While pharmacological and/or behavioral treatments are effective in managing symptoms for many patients with psychiatric diagnoses and disorders with behavioral/cognitive manifestations, a subset of individuals are treatment-refractory, unable to achieve appreciable …
While pharmacological and/or behavioral treatments are effective in managing symptoms for many patients with psychiatric diagnoses an …
Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use.
Winstanley EL, Thacker EP, Choo LY, Lander LR, Berry JH, Tofighi B. Winstanley EL, et al. Among authors: berry jh. Drug Alcohol Depend Rep. 2022 Sep 8;5:100091. doi: 10.1016/j.dadr.2022.100091. eCollection 2022 Dec. Drug Alcohol Depend Rep. 2022. PMID: 36844166 Free PMC article.
BACKGROUND: While barriers to accessing buprenorphine (BUP) therapy have been well described, little is known about pharmacy-related barriers. ...METHODS: Between July 2019 and March 2020, 139 participants receiving treatment for an opioid use disorder …
BACKGROUND: While barriers to accessing buprenorphine (BUP) therapy have been well described, little is known about pharmacy-r …
West Virginia's model of buprenorphine expansion: Preliminary results.
Winstanley EL, Lander LR, Berry JH, Mahoney JJ 3rd, Zheng W, Herschler J, Marshalek P, Sayres S, Mason J, Haut MW. Winstanley EL, et al. Among authors: berry jh. J Subst Abuse Treat. 2020 Jan;108:40-47. doi: 10.1016/j.jsat.2019.05.005. Epub 2019 May 8. J Subst Abuse Treat. 2020. PMID: 31221524 Free PMC article.
West Virginia (WV) is situated at the epicenter of the opioid epidemic with the highest rates of overdose deaths and some of the lowest rates of access to life saving evidence-based medication assisted treatment (MAT) for patients with opioid us …
West Virginia (WV) is situated at the epicenter of the opioid epidemic with the highest rates of overdose deaths and some of the lowe …
Safety and feasibility clinical trial of nucleus accumbens deep brain stimulation for treatment-refractory opioid use disorder.
Rezai AR, Mahoney JJ, Ranjan M, Haut MW, Zheng W, Lander LR, Berry JH, Farmer DL, Marton JL, Tirumalai P, Mears A, Thompson-Lake DGY, Finomore VS, D'Haese PF, Aklin WM, George DT, Corrigan JD, Hodder SL. Rezai AR, et al. Among authors: berry jh. J Neurosurg. 2023 Jun 9:1-9. doi: 10.3171/2023.4.JNS23114. Online ahead of print. J Neurosurg. 2023. PMID: 37329519
OBJECTIVE: There were more than 107,000 drug overdose deaths in the US in 2021, the most ever recorded. Despite advances in behavioral and pharmacological treatments, over 50% of those receiving treatment for opioid use disorder (OUD) experience drug use recu …
OBJECTIVE: There were more than 107,000 drug overdose deaths in the US in 2021, the most ever recorded. Despite advances in behavioral and p …
Timing of smoking cessation treatment integrated into outpatient treatment with medications for opioid use disorder: Feasibility trial.
Felicione NJ, Ozga JE, Dino G, Berry JH, Sullivan CR, Blank MD. Felicione NJ, et al. Among authors: berry jh. J Subst Abuse Treat. 2022 Jan;132:108579. doi: 10.1016/j.jsat.2021.108579. Epub 2021 Jul 31. J Subst Abuse Treat. 2022. PMID: 34452780 Free PMC article. Clinical Trial.
INTRODUCTION: Cigarette smoking rates among individuals with opioid use disorder (OUD) are notoriously high and may be improved by considering the timing of treatment integration for these two substances. The current study examined the feasibility of a method for as …
INTRODUCTION: Cigarette smoking rates among individuals with opioid use disorder (OUD) are notoriously high and may be improved by co …
Fatal self-injury in the United States, 1999-2018: Unmasking a national mental health crisis.
Rockett IRH, Caine ED, Banerjee A, Ali B, Miller T, Connery HS, Lulla VO, Nolte KB, Larkin GL, Stack S, Hendricks B, McHugh RK, White FMM, Greenfield SF, Bohnert ASB, Cossman JS, D'Onofrio G, Nelson LS, Nestadt PS, Berry JH, Jia H. Rockett IRH, et al. Among authors: berry jh. EClinicalMedicine. 2021 Feb 8;32:100741. doi: 10.1016/j.eclinm.2021.100741. eCollection 2021 Feb. EClinicalMedicine. 2021. PMID: 33681743 Free PMC article.
METHODS: For this state-based, cross-sectional, panel time series, we used de-identified manner and underlying cause-of-death data for the 50 states and District of Columbia (DC) from CDC's Wide-ranging Online Data for Epidemiologic Research. Procedures comprised joinpoint …
METHODS: For this state-based, cross-sectional, panel time series, we used de-identified manner and underlying cause-of-death data for the 5 …
High prevalence of co-occurring substance use in individuals with opioid use disorder.
Mahoney JJ 3rd, Winstanley EL, Lander LR, Berry JH, Marshalek PJ, Haut MW, Marton JL, Kimble WD, Armistead M, Wen S, Cai Y, Hodder SL. Mahoney JJ 3rd, et al. Among authors: berry jh. Addict Behav. 2021 Mar;114:106752. doi: 10.1016/j.addbeh.2020.106752. Epub 2020 Dec 4. Addict Behav. 2021. PMID: 33348147 Free PMC article.
OBJECTIVE: Funding to address the current opioid epidemic has focused on treatment of opioid use disorder (OUD); however, rates of other substance use disorders (SUDs) remain high and non-opioid related overdoses account for nearly 30% of overdoses. .. …
OBJECTIVE: Funding to address the current opioid epidemic has focused on treatment of opioid use disorder (OUD); howeve …
Deep brain stimulation of the nucleus accumbens/ventral capsule for severe and intractable opioid and benzodiazepine use disorder.
Mahoney JJ, Haut MW, Hodder SL, Zheng W, Lander LR, Berry JH, Farmer DL, Marton JL, Ranjan M, Brandmeir NJ, Finomore VS, Hensley JL, Aklin WM, Wang GJ, Tomasi D, Shokri-Kojori E, Rezai AR. Mahoney JJ, et al. Among authors: berry jh. Exp Clin Psychopharmacol. 2021 Apr;29(2):210-215. doi: 10.1037/pha0000453. Exp Clin Psychopharmacol. 2021. PMID: 34043402 Free PMC article.
Given high relapse rates and the prevalence of overdose deaths, novel treatments for substance use disorder (SUD) are desperately needed for those who are treatment refractory. ...DBS electrodes were implanted bilaterally within the Nucleus Accumbens/Ventral anterio …
Given high relapse rates and the prevalence of overdose deaths, novel treatments for substance use disorder (SUD) are desperately nee …
16 results